In First Cloud-Based STAC-M3 Benchmark, McObject and Lucera

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
In First Cloud-Based STAC-M3 Benchmark, McObject and Lucera Set Records for Market Data Analysis

FEDERAL WAY, WA and NEW YORK, NY--(Marketwired - Nov 19, 2014) - McObject®, developer of the eXtremeDB® Financial Edition database management system (DBMS) for capital markets, and Lucera Financial Infrastructures, a premier provider of on-demand high-performance infrastructure to power electronic trading, announced the availability of a STAC Report™ on the first cloud-based STAC-M3™ benchmark assessing high-speed analytics on time series trading data. McObject and Lucera also announced a partnership in which Lucera will offer eXtremeDB Financial Edition as a service for applications hosted on the Lucera Compute™ high-performance, collocated cloud computing infrastructure for financial institutions.

The partnership marks the first time that a low-latency DBMS has been ported to a cloud-based platform and offered as a service to its users.

In the tests conducted by the Securities Technology Analysis Center (STAC®), eXtremeDB Financial Edition and Lucera Compute achieved record-setting results executing complex queries that were designed by trading firms on the STAC Benchmark™ Council to reflect real-world capital markets computing demands. Together, the DBMS and cloud-based infrastructure beat standing records in five of the 17 benchmark tests. Compared to previous STAC-M3 benchmarks using different DBMSs, the McObject-Lucera pairing delivered performance that on average is

  • More than three times (3x) as fast as the best previously published result for the Multi-User Intervalized Statistics -- 50 Threads benchmark (STAC-M3.β1.50T.STATS-UI.TIME)
  • More than twice as fast for the Multi-User Intervalized Statistics -- 100 Threads benchmark (STAC-M3.β1.100T.STATS-UI.TIME)
  • More than twice as fast for the National Best Bid and Offer benchmark (STAC-M3.β1.1T.NBBO.TIME)

Clients will benefit from the speed of McObject's and Lucera's combined solution via more competitive trade execution, timely risk assessment, and improved strategy formulation via rapid back-testing all while using Lucera's on-demand compute capacity. eXtremeDB Financial Edition simplifies coding by enabling the use of SQL and Python in low-latency trading, and Lucera Compute™ eliminates the need for infrastructure build-out, thus reducing costs and cutting deployment time. eXtremeDB Financial Edition's built-in redundancy and recoverability combine with Lucera Compute's non-stop support and monitoring to provide the highest reliability for mission critical financial systems.

The fully audited STAC-M3 benchmark evaluated time-series data (tick database) management on four SmartOS instances of Lucera Compute™ (64 cores total). Clients written in Python accessed McObject's DBMS using the industry-standard SQL database programming language. Storage consisted of striped enterprise solid state drives instead of specialized low-latency storage devices. Tests utilized the DBMS's columnar data storage and vector-based statistical function library, and leveraged new features in eXtremeDB Financial Edition 6.0 including distributed query processing (the database was partitioned horizontally across 64 shards) and the ability to pipeline vector-based functions from within SQL.

"Organizations rely on Lucera to tame growing volumes of market data and gain the performance needed for successful trading, while managing costs and meeting regulatory requirements. The new STAC-M3 results confirm eXtremeDB Financial Edition's valuable role in helping to meet these goals. McObject is pleased with the benchmark outcome and also with our new partnership with Lucera, which makes eXtremeDB Financial Edition available as an on-demand service for the first time, adding a new dimension in flexibility for our customers," said Chris Mureen, chief operating officer of McObject.

"Financial services organizations historically have been slow to adopt cloud computing technology, which previously could not provide the combination of security, performance and reliability needed by our industry," said Jake Loveless, CEO of Lucera. "Through our partnership with McObject we are able to demonstrate that you can have the best of both worlds: the flexibility and economic efficiency of an on-demand infrastructure and the high performance necessary in today's competitive financial landscape. This benchmark was broken not using custom, on premises, high capex systems -- but rather using only four Lucera Compute™ instances collocated in the Equinix Chicago CH2 datacenter. From a price and performance perspective -- this is an entirely new level of value."

The performance of eXtremeDB Financial Edition on Lucera Compute, as evidenced by these STAC-M3 Benchmarks, recommends their use together in financial systems including:

  • Trade and order execution
  • Algorithmic back-testing of data
  • Real-time risk analytics and reporting
  • Correlation of trading and exposure across multiple asset classes and trading venues
  • Real-Time ingestion and analytics of high volume market/OPRA data

"STAC streamlines the efforts of the finance industry to evaluate new technology for strategic business tasks, with tests that are carefully audited and based on objective standards specified by financial firms. STAC-M3 Benchmarks are a rigorous way to understand the performance of technologies that can be used to manage tick data. Through this independently audited STAC Report, McObject has effectively used STAC-M3 to shed light on the performance potential of a previously untested combination of distributed database technology and a cloud architecture," said Peter Lankford, STAC founder and director.

The STAC-M3 Benchmark suite is the industry standard for testing solutions that enable high-speed analytics on time series data, such as tick-by-tick market data. See the full report at www.STACresearch.com/mcobject.

About McObject
Founded by embedded database and real-time systems experts, McObject offers proven data management technology that lends a competitive advantage to capital markets systems. McObject counts among its customers industry leaders such as TradeStation, NSE.IT, SunGard Kingstar, Transaction Network Services, Dalian Commodity Exchange, Financial Technologies of India Ltd. (FTIL), BAE Systems, Northrop Grumman, Siemens, Philips, EADS, Spirent Communications, F5 Networks, Motorola and Boeing. McObject, based in Federal Way, WA is committed to providing innovative technology and first-rate services to customers and partners. The company can be reached at +1-425-888-8505, or visit http://financial.mcobject.com.

About Lucera
Lucera Financial Infrastructures, LLC is a premier provider of on-demand, scalable high-performance infrastructure designed to power electronic connectivity and trading. Lucera's fast, open and intuitive platform is engineered to enable customers to securely leverage our powerful, high-speed and resilient electronic trading infrastructure. We empower our customers with on-demand provisioning and transparency that help them enhance performance, lower cost of operations and provide best in class service.

Lucera is a privately held, New York based firm launched with initial backing from Cantor Fitzgerald, a leading global financial services firm and active Lucera customer. Visit us at www.lucera.com.

McObject and eXtremeDB are registered trademarks of McObject LLC. All other company or product names mentioned herein are trademarks or registered trademarks of their respective owners.

Contact:
McObject
425-888-8505 ext. 213

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 509

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 537

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 0

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 523

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 441

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 349

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 400

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Thames Ventures VCT 1 PLC Reports Unaudited NAV for 2024

Updated Category News Views 81

Thames Ventures VCT 1 PLC Releases Unaudited NAV for 2024 Thames Ventures VCT 1 PLC has provided important updates about its financial status through its unaudited net asset value (NAV). As of June 30, 2024, the NAV stands at 45.9p per share. This announcement is significant for both the company and its investors, as understanding the NAV is essential for evaluating the...

Continue Reading
Gap Inc Achieves Impressive Growth and Market Expansion

Updated Category News Views 362

Gap Inc Reports Promising Financial Results Shares of Gap Inc (GAP) saw a significant uptick in early trading on Friday following the announcement of their latest quarterly results. This positive financial report highlighted a stronger performance than expected, showcasing the company's effective strategies and management efforts. Analysts' Positive Outlook on Gap In the...

Continue Reading
The Town Lake Company's Bold New Industrial Project Launch

Updated Category News Views 226

The Town Lake Company Initiates New Industrial Development Benchmark Business Parks, a division of The Town Lake Company, has proudly initiated construction on its latest small-bay industrial project. This significant development is located at 1433 Chris Lane and will encompass an impressive 84,200 square feet of innovative tilt-wall flex industrial space. The project is...

Continue Reading
Investors Unite in Class Action Against Everus Construction Group

Updated Category News Views 330

Opportunity for Investors in Everus Construction Group, Inc. In recent developments, investors of Everus Construction Group, Inc. (NYSE: ECG) have found themselves in the midst of a class action lawsuit that has drawn considerable attention. This lawsuit targets purchases made by investors during a specified period, raising important questions about the company's...

Continue Reading
Lam Research Board Approves Quarterly Dividend Announcement

Updated Category News Views 120

Lam Research Corporation Declares New Dividend Lam Research Corporation (Nasdaq: LRCX) has recently made an important announcement regarding its financial strategy. In their latest meeting, the company's Board of Directors approved a quarterly dividend of $0.23 per share for all common stockholders. This decision reflects Lam Research's commitment to providing value to...

Continue Reading